Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks--now moderated -- Ignore unavailable to you. Want to Upgrade?

To: Bucky Katt who wrote (214)	3/2/2004 4:39:30 PM
From: RikRichter	Respond to of 1338

SOTK .60/.70, $7MM market cap, stent coating systems with some insider buying recently: Sono-Tek Announces Its New AccuMist Stent Coating System Tuesday March 2, 4:03 pm ET MILTON, N.Y., March 2 /PRNewswire-FirstCall/ -- Sono-Tek Corporation (OTC Bulletin Board: SOTK - News), the world's leader in ultrasonic spray nozzle technology, today announced its first sales of the stand-alone AccuMist stent coating system, a tool designed for use in developing processes to spray coat arterial stents with polymers containing drugs that inhibit the development of scar tissue, which can lead to the recurrence of arterial blockage. Stents have been widely accepted by cardiologists. They have proven to be effective in alleviating constricted arteries. When implanted, their tubular mesh-like structure expands the arterial wall and allows blood to flow freely through the affected region. Historically, the drawback to this procedure has been the significant likelihood for the development of tissue cells around the stent, as part of the body's attempt to reject a foreign object. This condition is referred to as restinosis. Recent advances have led to the development of stents coated with biodegradable polymers containing drugs that inhibit cell formation, and which are slowly absorbed over a period of months, thereby greatly diminishing the probability of restinosis. Coated stent manufacturers have already proven that AccuMist ultrasonic spray nozzles are very effective in producing high quality stent coatings. The soft, precisely targeted spray produces uniform coatings, which are repeatable from one stent to the next. The new stand-alone AccuMist stent coating system incorporates this technology in a configuration designed to offer a high degree of flexibility for those engaged in the development of stent-coating processes in a laboratory setting. The stand-alone system contains facilities for programming both linear movement and rotation of the stent, and an easily accessible spray area for loading and unloading, as well as a precision liquid delivery system capable of providing an extraordinarily wide range of flow rates. According to Dr. Coccio, "This new product complements Sono-Tek's MediSonic coating system, designed for batch coating stents and other devices. The MediSonic system utilizes an ultrasonic nozzle spraying into a controlled vacuum environment to uniformly coat a large number of stents at the same time, while the AccuMist Stent Coating System is designed to coat single stents in an atmospheric environment." For further information, contact Dr. Christopher L. Coccio, President and CEO at 845-795-2020, or visit our website at www.sono-tek.com